Evidence map›Paper›PMID 38572386›Full record

ArticleClinical pediatric endocrinology : case reports and clinical investigations : official journal of the Japanese Society for Pediatric Endocrinology2024

Efficacy and safety of GH treatment in Japanese children with short stature due to

Tsutomu Ogata, Maki Fukami, Kazunori Tanizawa, Tatsuyoshi Yamamoto, Yuji Sato, Hideaki Hirai, Naoko Takasao, Ryo Ibaraki, Marin Noda

Open access · diamondAbstract read
In one paragraph

Article in Clinical pediatric endocrinology : case reports and clinical investigations : official journal of the Japanese Society for Pediatric Endocrinology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.6field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 citations in OpenAlex.

  1. Idiopathic short stature in the genomic era: a focused narrative review of genotype-phenotype correlation, selective neuroimaging, IGF-1 biology, and growth hormone responsiveness.Clinical pediatric endocrinology : case reports and clinical investigations : official journal of the Japanese Society for Pediatric Endocrinology · 2026
    Review
  2. Efficacy and safety of GH treatment in Japanese pediatric patients withClinical pediatric endocrinology : case reports and clinical investigations : official journal of the Japanese Society for Pediatric Endocrinology · 2026
    Article
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Tsutomu OgataDepartment of Pediatrics and Biochemistry, Hamamatsu University School of Medicine, Hamamatsu, Japan.
Maki FukamiDepartment of Molecular Endocrinology, National Research Institute for Child Health and Development, Tokyo, Japan.
Kazunori TanizawaDevelopment Division, JCR Pharmaceuticals, Ashiya, Japan.
Tatsuyoshi YamamotoDevelopment Division, JCR Pharmaceuticals, Ashiya, Japan.
Yuji SatoDevelopment Division, JCR Pharmaceuticals, Ashiya, Japan.
Hideaki HiraiDevelopment Division, JCR Pharmaceuticals, Ashiya, Japan.
Naoko TakasaoDevelopment Division, JCR Pharmaceuticals, Ashiya, Japan.
Ryo IbarakiDevelopment Division, JCR Pharmaceuticals, Ashiya, Japan.
Marin NodaDevelopment Division, JCR Pharmaceuticals, Ashiya, Japan.
JCR Pharmaceuticals (Japan) · JPHamamatsu University · JPNational Center For Child Health and Development · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We conducted a randomized phase 3 study to investigate the efficacy and safety of GH treatment in prepubertal Japanese patients with short stature due to

Indexed as

GHphase 3 clinical trialshort statureSHOX deficiency

Identifiers

PMID38572386
PMCPMC10985015
OpenAlexW4391284074

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.